Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine


  1. Published

    K65R with and withourt S68: A new resistance profile in vivo detected in most patients failing abacavir, didanosine and stavudine.

    Røge, B., Katzenstein, T., Obel, N., Pedersen, C., Mathiesen, L. R., Lundgren, Jens & Gerstoft, J., 2003, In: Antiviral Therapy.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited.

    Moore, A., Kirk, O., Johnson, A., Katlama, C., Blaxhult, A., Dietrich, M., Colebunders, R., Chiesi, A., Lundgren, Jens & Phillips, A., 2003, In: J A I D S.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

    Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A. & Lundgren, Jens, 2003, In: Lancet.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Virological rebound after suppression o­n highly active antiretroviral therapy.

    Mocroft, A., Ruiz, L., Reiss, P., Ledergerber, B., Katlama, C., Lazzarin, A., Goebel, F., Phillips, A., Clotet, B. & Lundgren, Jens, 2003, In: AIDS.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Anemia and survival in human immunodeficiency virus.

    Lundgren, Jens & Mocroft, A., 2003, In: Clinical Infectious Diseases. 37 Suppl 4, p. 297-303 7 p.

    Research output: Contribution to journalJournal articleResearch

  6. Published

    Dyslipidaemia and cardiovascular disease risk associated with antiretroviral drugs.

    Lundgren, Jens, 2003, In: Pharmacoepidemiology and Drug Safety.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Modelling the three year risk of myocardial infarction among participants in the D:A:D study

    Law, M., Friis-Møller, N., Weber, R., Reiss, P., Thiebaut, R., Kirk, O., Monforte, A. D., Pradier, C., Morfeldt, L., Calvo, G., El-Sadr, W., Wit, S. D., Sabin, C. & Lundgren, Jens, 2003, In: HIV Medicine.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors

    Kirk, O., Lundgren, Jens, Pedersen, C., Mathiesen, L. R., Nielsen, H., Katzenstein, T. L., Obel, N. & Gerstoft, J., 2003, In: Antiviral Therapy. 8, 6, p. 595-602 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Low efficacy and high frequency of adverse event in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.

    Gerstoft, J., Kirk, O., Obel, N., Pedersen, C., Mathiesen, L. R., Nielsen, H., Katzenstein, T. & Lundgren, Jens, 2003, In: AIDS.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Combination Antiretroviral Therapy and the Risk of Myocardial Infarction. The Data Collection o­n Adverse Events of Anti-HIV Drugs for the D:A:D Study Group.

    Friis-Møller, N., Sabin, C., Weber, R., Monforte, A. D., El-Sadr, W., Reiss, P., Thiebaut, R., Morfeldt, L., Wit, S. D., Pradier, C., Calvo, G., Law, M., Kirk, O., Phillips, A. & Lundgren, Jens, 2003, In: New England Journal of Medicine.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 13961